医药高增长轮动策略:年化收益率(-1.81%)
本策略精选医药生物行业中,净利润和营收均高速增长、毛利率和净利率优秀、市盈率适中,且流通市值较小的优质股票。策略通过严格的财务指标筛选,并结合小市值偏好,力求捕捉医药行业中具备高成长潜力的投资标的,并进行短期轮动持有,以期获得超额收益。
本策略精选医药生物行业中,净利润和营收均高速增长、毛利率和净利率优秀、市盈率适中,且流通市值较小的优质股票。策略通过严格的财务指标筛选,并结合小市值偏好,力求捕捉医药行业中具备高成长潜力的投资标的,并进行短期轮动持有,以期获得超额收益。
查看AI策略代码
当日收盘价 | 当日市值 | 浮动收益/浮动收益率
|
|||||
---|---|---|---|---|---|---|---|
2025-06-26 | 甘李药业(603087.SH) | 48.368603968939 | 1830 | 36 | 53.49 | 97886.7 | 9372.15/10.588% |
2025-06-26 | 昊帆生物(301393.SZ) | 48.364578054629 | 1909 | 36 | 49.94 | 95335.46 | 3007.48/3.257% |
2025-06-26 | 大博医疗(002901.SZ) | 33.655879985364 | 2733 | 41 | 35.48 | 96966.84 | 4985.32/5.42% |
2025-06-26 | 宣泰医药(688247.SH) | 10.752347506537 | 9595 | 156 | 10.12 | 97101.4 | -6067.37/-5.881% |
2025-06-26 | 特宝生物(688278.SH) | 61.435341940248 | 1239 | 296 | 72.17 | 89418.63 | 13300.24/17.473% |
2025-06-25 | 甘李药业(603087.SH) | 48.368603968939 | 1830 | 35 | 54.38 | 99515.4 | 11000.85/12.428% |
2025-06-25 | 昊帆生物(301393.SZ) | 48.20617993714 | 1809 | 35 | 51.16 | 92548.44 | 5343.46/6.127% |
2025-06-25 | 大博医疗(002901.SZ) | 33.655879985364 | 2733 | 40 | 35.85 | 97978.05 | 5996.53/6.519% |
2025-06-25 | 宣泰医药(688247.SH) | 10.752347506537 | 9595 | 155 | 10.13 | 97197.35 | -5971.42/-5.788% |
2025-06-25 | 特宝生物(688278.SH) | 61.435341940248 | 1239 | 295 | 72.06 | 89282.34 | 13163.95/17.294% |
2025-06-26 | 昊帆生物(301393.SZ) | 买 | 100 | 51.18 | 5118 | ¥5 | 0 |
2025-06-19 | 大博医疗(002901.SZ) | 买 | 100 | 35.5 | 3550 | ¥5 | 0 |
2025-06-12 | 兴齐眼药(300573.SZ) | 卖 | -1700 | 53.51 | -90967 | ¥118.26 | -3921.46 |
2025-06-12 | 宣泰医药(688247.SH) | 卖 | -300 | 10.51 | -3153 | ¥8.15 | -72.7 |
2025-06-11 | 甘李药业(603087.SH) | 买 | 30 | 57.73 | -50.1 | ¥0 | 0 |
2025-06-05 | 宣泰医药(688247.SH) | 卖 | -300 | 10.19 | -3057 | ¥8.06 | -168.7 |
2025-06-05 | 昊帆生物(301393.SZ) | 卖 | -100 | 55.6 | -5560 | ¥10.56 | 739.38 |
2025-06-05 | 兴齐眼药(300573.SZ) | 买 | 1700 | 55.8 | 94860 | ¥28.46 | 0 |
2025-06-05 | 甘李药业(603087.SH) | 卖 | -100 | 57.16 | -5716 | ¥10.72 | 798.53 |
2025-05-30 | 大博医疗(002901.SZ) | 买 | 33 | 38.02 | -19.34 | ¥0 | 0 |